Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset

D A Wooten1, L G Winston

  • 1University of California, San Francisco, Department of Internal Medicine, USA. darcy.wooten@ucsf.edu

Respiratory Medicine
|June 13, 2013
PubMed
Abstract

Insights

Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia differ by community or hospital onset. Tobacco use, COPD, and antibiotic exposure are key risks, while recent hospitalization unexpectedly decreased MRSA pneumonia risk.

Area of Science:

  • Infectious Diseases
  • Pulmonary Medicine
  • Critical Care Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia risk factors are not fully understood.
  • Community-acquired and hospital-acquired pneumonia may have distinct risk profiles.
  • Characterizing these factors is crucial for effective prevention and treatment strategies.

Purpose of the Study:

  • To identify and compare risk factors for MRSA pneumonia based on the site of infection onset (community vs. hospital).
  • To investigate the influence of various patient characteristics and exposures on MRSA pneumonia development.

Main Methods:

  • A case-control study involving 619 adult patients hospitalized between 2005 and 2010.
  • Patients were categorized by MRSA or methicillin-sensitive S. aureus (MSSA) pneumonia.
  • Pneumonia onset was classified as community-onset (culture within 48 hours of admission) or hospital-onset (culture after 48 hours).

Main Results:

  • For community-onset MRSA pneumonia, risk factors included tobacco use (OR 2.31), COPD (OR 3.76), and recent antibiotic exposure (OR 4.87).
  • For hospital-onset MRSA pneumonia, risk factors included tobacco use (OR 2.66), illicit drug use (OR 3.52), and recent antibiotic exposure (OR 2.04).
  • Recent hospitalization (within 3 months) was associated with a decreased risk of MRSA pneumonia (OR 0.64).

Conclusions:

  • Common and distinct risk factors for MRSA pneumonia exist depending on community or hospital onset.
  • Tobacco use, COPD, illicit drug use, and recent antibiotic exposure are significant risk factors.
  • The finding that recent hospitalization decreases MRSA pneumonia risk is unexpected and requires further research.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...